DOE Patents title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Identification of cancer protein biomarkers using proteomic techniques

Abstract

The claimed invention describes methods to diagnose or aid in the diagnosis of cancer. The claimed methods are based on the identification of biomarkers which are particularly well suited to discriminate between cancer subjects and healthy subjects. These biomarkers were identified using a unique and novel screening method described herein. The biomarkers identified herein can also be used in the prognosis and monitoring of cancer. The invention comprises the use of leptin, prolactin, OPN and IGF-II for diagnosing, prognosis and monitoring of ovarian cancer.

Inventors:
; ;
Issue Date:
Research Org.:
Yale Univ., New Haven, CT (United States)
Sponsoring Org.:
USDOE
OSTI Identifier:
1329309
Patent Number(s):
9470688
Application Number:
14/602,916
Assignee:
Yale University (New Haven, CT
Patent Classifications (CPCs):
C - CHEMISTRY C12 - BIOCHEMISTRY C12Q - MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS
G - PHYSICS G01 - MEASURING G01N - INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
DOE Contract Number:  
FG02-ER63462
Resource Type:
Patent
Resource Relation:
Patent File Date: 2015 Jul 22
Country of Publication:
United States
Language:
English
Subject:
59 BASIC BIOLOGICAL SCIENCES; 60 APPLIED LIFE SCIENCES

Citation Formats

Mor, Gil G., Ward, David C., and Bray-Ward, Patricia. Identification of cancer protein biomarkers using proteomic techniques. United States: N. p., 2016. Web.
Mor, Gil G., Ward, David C., & Bray-Ward, Patricia. Identification of cancer protein biomarkers using proteomic techniques. United States.
Mor, Gil G., Ward, David C., and Bray-Ward, Patricia. Tue . "Identification of cancer protein biomarkers using proteomic techniques". United States. https://www.osti.gov/servlets/purl/1329309.
@article{osti_1329309,
title = {Identification of cancer protein biomarkers using proteomic techniques},
author = {Mor, Gil G. and Ward, David C. and Bray-Ward, Patricia},
abstractNote = {The claimed invention describes methods to diagnose or aid in the diagnosis of cancer. The claimed methods are based on the identification of biomarkers which are particularly well suited to discriminate between cancer subjects and healthy subjects. These biomarkers were identified using a unique and novel screening method described herein. The biomarkers identified herein can also be used in the prognosis and monitoring of cancer. The invention comprises the use of leptin, prolactin, OPN and IGF-II for diagnosing, prognosis and monitoring of ovarian cancer.},
doi = {},
journal = {},
number = ,
volume = ,
place = {United States},
year = {Tue Oct 18 00:00:00 EDT 2016},
month = {Tue Oct 18 00:00:00 EDT 2016}
}

Works referenced in this record:

Detection of neoplasms by hormonal tumor stimulation test
patent, December 1996


Method for inhibiting neoplastic disease in mammals
patent, June 2000


Gene expression in bladder tumors
patent, January 2002


Isolated ductal fluid sample
patent, November 2003


Identification of cancer protein biomarkers using proteomic techniques
patent, February 2010


Diagnostic marker for tumor hypoxia and prognosis
patent-application, March 2003


Downregulation of long-form prolactin receptor mRNA during prolactin-induced luteal regression
journal, August 2000


Utility of osteopontin as a biomarker in recurrent epithelial ovarian cancer
journal, May 2004


Expression of Leptin Receptors and Potential Effects of Leptin on the Cell Growth and Activation of Mitogen-Activated Protein Kinases in Ovarian Cancer Cells
journal, January 2005


Fasting Ghrelin Levels in Physically Active Women: Relationship with Menstrual Disturbances and Metabolic Hormones
journal, July 2004


The Functional and Clinical Roles of Osteopontin in Cancer and Metastasis
journal, November 2001


Multiplexed Immunobead-Based Cytokine Profiling for Early Detection of Ovarian Cancer
journal, April 2005


Multiple Kinase Cascades Mediate Prolactin Signals to Activating Protein-1 in Breast Cancer Cells
journal, December 2004


Enhanced Expression of Leptin and Leptin Receptor (OB-R) in Human Breast Cancer
journal, July 2004


Progress and Challenges in Screening for Early Detection of Ovarian Cancer
journal, February 2004


Use of serum prolactin for monitoring the therapeutic response in ovarian malignancy
journal, September 1991


Leptin directly stimulates aromatase activity in human luteinized granulosa cells
journal, August 1999


Serum Vascular Endothelial Growth Factor and Serum Leptin in Patients with Cervical Cancer
journal, April 2002


Prolactin increases HO-1 expression and induces VEGF production in human macrophages
journal, January 2004


Circulating levels of insulin-like growth factor-II and IGF-binding protein 3 in cervical cancer
journal, December 2003


Combining CA 125 and SMR serum markers for diagnosis and early detection of ovarian carcinoma
journal, October 2004


Serum protein markers for early detection of ovarian cancer
journal, May 2005


Therapeutic Implications of Immune-endocrine Interactions in the Critically Ill Patients
journal, June 2004


Prolactin acts as a potent survival factor for human breast cancer cell lines
journal, June 2004


Prolactin as a tumour marker in cancer of the cervix
journal, January 1998


Use of proteomic patterns in serum to identify ovarian cancer
journal, February 2002


Serum tumor markers in colorectal cancer staging, grading, and follow-up
journal, August 1996


Role of osteopontin in tumour progression
journal, April 2004


Obesity, adipocytokines, and insulin resistance in breast cancer
journal, August 2004


Multiplexed protein profiling on microarrays by rolling-circle amplification
journal, April 2002


Cancer screening in a high risk population: a clinical trial
journal, April 2001


Leptin expression in colorectal and breast cancer patients.
journal, April 2000


Plasma Prolactin Concentrations and Risk of Postmenopausal Breast Cancer
journal, September 2004


Osteopontin is a potential target gene in mouse mammary cancer chemoprevention by Se-methylselenocysteine
journal, July 2004


Diagnostic Markers for Early Detection of Ovarian Cancer
journal, February 2008


The role of Osteopontin in tumor metastasis
journal, October 2004


The metastasis gene osteopontin: a candidate target for cancer therapy
journal, December 2001


Differential Gene Expression in Chemically Induced Mouse Lung Adenomas
journal, January 2003


Ovarian dysgerminoma showing high serum levels and positive immunostaining of placental alkaline phosphatase and neuron-specific enolase associated with elevation of serum prolactin level
journal, October 1998


Three Biomarkers Identified from Serum Proteomic Analysis for the Detection of Early Stage Ovarian Cancer
journal, August 2004